Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein

European Journal of Neuroscience

Volumn 24, Issue 1, 2006, Pages 55-64

  Wersinger, Christophe ^a   Rusnak, Milan ^a   Sidhu, Anita ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

synuclein; Alcoholism; Depression; Protein protein interactions; Serotonin homeostasis; Serotonin transporter trafficking

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; CELL SURFACE PROTEIN; SEROTONIN TRANSPORTER;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CELL MEMBRANE TRANSPORT; COMPLEX FORMATION; CONTROLLED STUDY; DEPRESSION; DNA ADDUCT; EMBRYO; FEMALE; FUNCTIONAL PROTEOMICS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; NEUROMODULATION; NEUROPHYSIOLOGY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; SEROTONIN UPTAKE; SIGNAL TRANSDUCTION; TRANSPORT KINETICS;

ALPHA-SYNUCLEIN; ANIMALS; CELL MEMBRANE; CELLS, CULTURED; DNA; HUMANS; IMMUNOHISTOCHEMISTRY; NEURONS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RAPHE NUCLEI; RATS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; THALAMUS; TRANSFECTION;

EID: 33745908304     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.04900.x     Document Type: Article

References (52)

1. Adell, A., Celada, P., Abellan, M.T. & Artigas, F. (2002) Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res. Rev., 39, 154-180.
2. Bauman, A.L., Apparsundaram, S., Ramamoorthy, S., Wadzinski, B.E., Vaughan, R.A. & Blakely, R.D. (2000) Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J. Neurosci., 20, 7571-7578.
3. Bennett, M.C. (2005) The role of alpha-synuclein in neurodegenerative diseases. Pharmacol. Ther., 105, 311-331.
4. Blakely, R.D., Ramamoorthy, S., Schroeter, S., Qian, Y., Apparsundaram, S., Galli, A. & DeFelice, L.J. (1998) Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol. Psychiatry, 44, 169-178.
5. Bruning, G. & Liangos, O. (1997) Transient expression of the serotonin transporter in the developing mouse thalamocortical system. Acta Histochem., 99, 117-121.
6. Clayton, D.F. & George, J.M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci., 21, 249-254.
7. Flattem, N.L. & Blakely, R.D. (2000) Modified structure of the human serotonin transporter promoter. Mol. Psychiatry, 5, 110-115.
8. George, J.M. (2002) The synucleins. Genome Biol., 3, 1-6.
9. Giasson, B.I., Duda, J.E., Forman, M.S., Lee, V.M. & Trojanowski, J.Q. (2001) Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons. Exp. Neurol., 172, 354-362.
10. Haase, J., Killian, A.M., Magnani, F. & Williams, C. (2001) Regulation of the serotonin transporter by interacting proteins. Biochem. Soc. Trans., 29, 722-728.
11. Hahn, M.K. & Blakely, R.D. (2002) Monamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J., 25, 487-495.
12. Heinz, A., Mann, K., Weinberger, D.R. & Goldman, D. (2001) Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin. Exp. Res., 25, 487-495.
13. Jayanthi, L.D. & Ramamoorthy, S. (2005) Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J., 7, E728-E738.
14. Jellinger, K.A. (1991) Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol. Chem. Neuropathol., 14, 153-197.
15. Jellinger, K.A. (2000) Morphological substrates of mental dysfunction in Lewy body disease: an update. J. Neural Transm. Suppl., 59, 185-212.
16. Jess, U., El Far, O., Kirsch, J. & Betz, H. (2002) Interaction of the C-terminal region of the rat serotonin transporter with MacMARCKS modulates 5-HT uptake regulation by protein kinase C. Biochem. Biophys. Res. Commun., 294, 272-279.
17. Lebrand, C., Cases, O., Adelbrecht, C., Doye, A., Alvarez, C., El Mestikawy, S., Seif, I. & Gaspar, P. (1996) Transient uptake and storage of serotonin in developing thalamic neurons. Neuron, 17, 823-835.
18. Maries, E., Dass, B., Collier, T.J., Kordower, J.H. & Steece-Collier, K. (2003) The role of alpha-synuclein in Parkinson's disease: insights from animal models. Nat. Rev. Neurosci., 4, 727-738.
19. Maron, E., Kuikka, J.T., Shlik, J., Vasar, V., Vanninen, E. & Tiihonen, J. (2004) Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res., 132, 173-181.
20. Maroteaux, L. & Scheller, R.H. (1991) The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Brain Res. Mol. Brain Res., 11, 335-343.
21. McCauley, J.H., Olson, I.M., Dowd, M., Amin, T., Steele, A., Blakely, R.D., Folstein, S.E., Haines, J.L. & Sutcliffe, J.S. (2004) Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid compulsive subset of autism. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 127, 104-112.
22. Moussa, C.E.-H., Wersinger, C., Tomita, Y. & Sidhu, A. (2004) Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Biochemistry, 43, 5539-5550.
23. Murai, T., Muller, U., Werheid, K., Sorger, D., Reuter, M., Becker, T., von Cramon, D.Y. & Barthel, H. (2001) In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease. J. Neuropsychiatry Clin. Neurosci., 13, 222-228.
24. Murphy, D.L., Li, Q., Engel, S., Wichems, C., Andrews, A., Lesch, K.P. & Uhl, G. (2001) Genetic perspectives on the serotonin transporter. Brain Res. Bull., 56, 487-494.
25. Najib, A., Pelliccioni, P., Gil, C. & Aguilera, J. (2000) Serotonin transporter phosphorylation modulated by tetanus toxin. FEBS Lett., 486, 136-142.
26. - neurotransmitter transporters. J. Neurochem., 71, 1785-1803.
27. Owens, M.J. & Nemeroff, C.B. (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem., 40, 288-295.
28. Ozaslan, D., Wang, S., Ahmed, B.A., Kocabas, A.M., McCastlain, J.C., Bene, A. & Kilic, F. (2003) Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues. J. Biol. Chem., 278, 43991-44000.
29. Qian, Y., Galli, A., Ramamoorthy, S., Risso, S., DeFelice, L.J. & Blakely, R.D. (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci., 17, 45-57.
30. Quick, M.W. (2003) Role of syntaxin 1A on serotonin transporter expression in developing thalamocortical neurons. Int. J. Dev. Neurosci., 20, 219-224.
31. Ramamoorthy, S. & Blakely, R.D. (1999) Phosphorylation and sequestration of serotonin tranporters differentially modulated by psychostimulants. Science, 285, 763-766.
32. Ramamoorthy, S., Giovanetti, E., Qian, Y. & Blakely, R.D. (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J. Biol. Chem., 273, 2458-2466.
33. Rothman, R.B. & Baumann, M.H. (2003) Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol., 479, 23-40.
34. Sakai, N., Sasaki, K., Nakashita, M., Honda, S., Ikegaki, N. & Saito, N. (1997) Modulation of serotonin transporter activity by a protein kinase C activator and an inhibitor of type 1 and 2A serine/threonine phosphatases. J. Neurochem., 68, 2618-2624.
35. Schloss, P. & Williams, D.C. (1998) The serotonin transporter: a primary target for antidepressant drugs. J. Psychopharmacol., 12, 115-121.
36. Sidhu, A., Wersinger, C., Moussa, C.E. & Vernier, P. (2004c) The role of alpha-synuclein in both neuroprotection and neurodegeneration. Ann. NY Acad. Sci., 1035, 250-270.
37. Sidhu, A., Wersinger, C. & Vernier, P. (2004a) Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J., 18, 637-647.
38. Sidhu, A., Wersinger, C. & Vernier, P. (2004b) Alpha-synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease. FEBS Lett., 565, 1-5.
39. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M.R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J. & Gwinn-Hardy, K. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science, 302, 841.
40. Torres, G.E., Gainetdinov, R.R. & Caron, M.G. (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci., 4, 13-25.
41. Totterdell, S., Hanger, D. & Meredith, G.E. (2004) The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain. Brain Res., 1004, 61-72.
42. Vekrellis, K., Rideout, H.J. & Stefanis, L. (2004) Neurobiology of alpha-synuclein. Mol. Neurobiol., 30, 1-21.
43. Watson, R.E. Jr, Wiegand, S.J., Clough, R.W & Hoffman, G.E. (1986) Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides, 7, 155-159.
44. Wersinger, C., Banta, M. & Sidhu, A. (2004a) Comparative analyses of alpha-synuclein expression levels in rat brain tissues and transfected cells. Neurosci. Lett., 358, 95-98.
45. Wersinger, C., Prou, D., Vernier, P., Niznik, H.B. & Sidhu, A. (2003b) Mutations in the lipid-binding domain of α-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity. Mol. Cell. Neurosci., 24, 91-105.
46. Wersinger, C., Prou, D., Vernier, P. & Sidhu, A. (2003a) Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J., 17, 2151-2153.
47. Wersinger, C. & Sidhu, A. (2003) Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci. Lett., 340, 189-192.
48. Wersinger, C. & Sidhu, A. (2005) Disruption of the interaction of α-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Biochemistry, 44, 13612-13624.
49. Wersinger, C., Vernier, P. & Sidhu, A. (2004b) Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant. Biochemistry, 43, 1242-1253.
50. - dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther., 92, 21-55.
51. Zhu, C.B., Carneiro, A.M., Dostmann, W.R., Hewlett, W.A. & Blakely, R.D. (2005) p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J. Biol. Chem., 280, 15649-15658.
52. Zhu, C.B., Hewlett, W.A., Feoktistov, I., Biaggioni, I. & Blakely, R.D. (2004) Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol. Pharmacol., 65, 1462-1474.